Fasting plasma glucose and HbA1c in cardiovascular risk prediction: A sex-specific comparison in individuals without diabetes mellitus

Diabetologia

Volumn 56, Issue 1, 2013, Pages 92-100

  Schottker B ^a   Muller H ^a   Rothenbacher, D ^a,b   Brenner, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Blood glucose; Cardiovascular diseases; Cohort study; Diabetes mellitus, type 2; Epidemiology; HbA1c; Prediabetes; Prediction

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC CORONARY RISK EVALUATION CHART;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX FACTORS;

EID: 84871619724     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2707-x     Document Type: Article

References (34)

1. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N (2011) Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med 171:404-410
2. Sarwar N, Aspelund T, Eiriksdottir G et al. (2010) Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med 7:e1000278
3. Hanna-Moussa A, Gardner MJ, Kurukulasuriya LR, Sowers JR (2009) Dysglycemia/prediabetes and cardiovascular risk factors. Rev Cardiovasc Med 10:202-208
4. Consensus Committee (2007) Consensus statement on the worldwide standardization of the hemoglobin A1C measurement. The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 30:2399-2400 (Pubitemid 47359053)
5. American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35(Suppl 1):S64-S71
6. Ford ES, Zhao G, Li C (2010) Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 55:1310-1317
7. Selvin E, Steffes MW, Zhu H et al. (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:800-811
8. Cederberg H, Saukkonen T, Laakso M et al. (2010) Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care 33:2077-2083
9. Simmons RK, Sharp S, Boekholdt SM et al. (2008) Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events? Arch Intern Med 168:1209-1216 (Pubitemid 351831404)
10. Bersoux S, Cook CB, Wu Q et al. (2011) Hemoglobin A1c testing alone does not sufficiently identify patients with prediabetes. Am J Clin Pathol 135:674-677
11. Lorenzo C, Wagenknecht LE, Hanley AJ, Rewers MJ, Karter AJ, Haffner SM (2010) A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 33:2104-2109
12. Schöttker B, Raum E, Rothenbacher D, Müller H, Brenner H (2011) Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening. Eur J Epidemiol 26:779-787
13. American Diabetes Association (2010) Standards of medical care in diabetes-2010. Diabetes Care 33(Suppl 1):S11-S61
14. 1c standardisation: history, science and politics. Clin Biochem Rev 28:163-168
15. Conroy RM, Pyorala K, Fitzgerald AP et al. (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987-1003 (Pubitemid 36712275)
16. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157-172 (Pubitemid 351193639)
17. Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928-935 (Pubitemid 46294733)
18. Cook NR (2010) Methods for evaluating novel biomarkers - a new paradigm. Int J Clin Pract 64:1723-1727
19. Brunner EJ, Shipley MJ, Marmot MG, Kivimaki M, Witte DR (2010) Do the Joint British Society (JBS2) guidelines on prevention of cardiovascular disease with respect to plasma glucose improve risk stratification in the general population? Prospective cohort study. Diabet Med 27:550-555
20. Sarwar N, Gao P, Seshasai SR et al. (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215-2222
21. Löw M, Stegmaier C, Ziegler H, Rothenbacher D, Brenner H (2004) [Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population (ESTHER study)]. Dtsch Med Wochenschr 129:2643-2647 [article in German] (Pubitemid 39655908)
22. Raum E, Rothenbacher D, Löw M, Stegmaier C, Ziegler H, Brenner H (2007) Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach. Eur J Cardiovasc Prev Rehabil 14:809-814 (Pubitemid 350197011)
23. Cooney MT, Dudina A, de Bacquer D et al. (2009) How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil 16:304-314
24. May S, Hosmer DW (2004) A cautionary note on the use of the Gronnesby and Borgan goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal 10:283-291 (Pubitemid 39073127)
25. Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P (2010) Impact of HbA1c screening criterion on the diagnosis of pre-diabetes among US adults. Diabetes Care 33:2190-2195
26. Balkau B, Soulimane S, Lange C, Gautier A, Tichet J, Vol S (2011) Are the same clinical risk factors relevant for incident diabetes defined by treatment, fasting plasma glucose, and HbA1c? Diabetes Care 34:957-959
27. Pajunen P, Koukkunen H, Ketonen M et al. (2005) Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI study. Diabetologia 48:2519-2524 (Pubitemid 41738217)
28. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J (2005) Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 48:856-861 (Pubitemid 40767977)
29. Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL (2003) Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 163:1735-1740 (Pubitemid 36898963)
30. Selvin E, Marinopoulos S, Berkenblit G et al. (2004) Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421-431
31. Hamer M, Chida Y, Stamatakis E (2009) Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases. Am J Cardiol 104:538-542
32. Lauritzen T, Sandbaek A, Skriver K, Borch-Johnson K (2011) HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark. Diabetologia 54:1318-1326
33. Li G, Zhang P, Wang J et al. (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371:1783-1789 (Pubitemid 351697954)
34. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey SG (2011) Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev, Issue 1, Art. no.: CD001561. doi: 10.1002/14651858.CD001561.pub3